Cultivation of Yellow Fever Virus in Human Explants

Abstract

It is deduced from tentative results of pathogenicity tests with monkeys, that strain 17 D has not lost its original quality after more than 145 passages through human explants. A reversion to the viscerotropic form, such as the one apparently achieved by Findlay and Clarke by monkey liver passage of the French neurotropic strain, could not be demonstrated. The loss of viscerotropy shown by the pantropic Asibi strain is noteworthy because it proved the independence of this mutation from the species-specific origin of the explanted tissue, i.e. it takes place also in tissue explants of the natural host.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 1968
Accession Number
AD0846558

Entities

People

  • C. Hallauer

Organizations

  • United States Army Biological Warfare Laboratories

Tags

DTIC Thesaurus Topics

  • Dilution
  • Export Controls
  • Government (Foreign)
  • Governments
  • Infection
  • Intervals
  • Materials
  • Metal Matrix Composites
  • Sensitivity
  • Tissue Culture
  • Titration
  • Viruses
  • Wound Infections
  • Yellow Fever

Readers

  • Aquatic Ecology
  • Toxicology/Environmental Toxicology
  • Virology (or Medical Virology).